Your browser doesn't support javascript.
loading
The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
Buck, Amanda M; Deitchman, Amelia N; Takahashi, Saki; Lu, Scott; Goldberg, Sarah A; Bodansky, Aaron; Kung, Andrew; Hoh, Rebecca; Williams, Meghann C; Kerbleski, Marian; Maison, David P; Deveau, Tyler-Marie; Munter, Sadie E; Lombardo, James; Wrin, Terri; Petropoulos, Christos J; Durstenfeld, Matthew S; Hsue, Priscilla Y; Kelly, J Daniel; Greenhouse, Bryan; Martin, Jeffrey N; Deeks, Steven G; Peluso, Michael J; Henrich, Timothy J.
Afiliación
  • Buck AM; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Deitchman AN; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Takahashi S; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Lu S; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Goldberg SA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Bodansky A; Division of Pediatric Critical Care Medicine, University of California San Francisco, San Francisco, California, USA.
  • Kung A; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Hoh R; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Williams MC; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Kerbleski M; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Maison DP; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Deveau TM; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Munter SE; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Lombardo J; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Wrin T; Monogram Biosciences, South San Francisco, California, USA.
  • Petropoulos CJ; Monogram Biosciences, South San Francisco, California, USA.
  • Durstenfeld MS; Division of Cardiology, University of California San Francisco, San Francisco, California, USA.
  • Hsue PY; Division of Cardiology, University of California San Francisco, San Francisco, California, USA.
  • Kelly JD; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Greenhouse B; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Martin JN; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Henrich TJ; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
J Med Virol ; 95(11): e29216, 2023 11.
Article en En | MEDLINE | ID: mdl-37988251

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Síndrome Post Agudo de COVID-19 Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Síndrome Post Agudo de COVID-19 Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos